(Total Views: 61)
Posted On: 07/22/2020 1:30:46 PM
Post# of 85677
$JAZZ News Article - Jazz Pharmaceuticals Announces U.S. FDA Approval of Xywav(TM) (calcium, magnesium, potassium, and sodium oxybates) Oral Solution for Cataplexy or Excessive Daytime Sleepiness Associated with Narcolepsy https://marketwirenews.com/news-releases/jazz...02447.html
(0)
(0)
My Twitter: WhyteStocks
